newsfilter
← Latest News
GlobeNewswire·

TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Upcoming oral presentation for the ALLOHATM Phase 1 heme trial at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition Company to host virtual KOL event featuring Ran Reshef, M.D., M.Sc., on